New scan and urine test could revolutionize bladder cancer staging

NCT ID NCT07257718

Not yet recruiting Diagnosis Sponsor: Chiti Arturo Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether a special PET scan (FAPI PET) and simple urine tests can better determine the stage of bladder cancer compared to standard methods. About 262 adults with bladder cancer will receive the scan and provide urine samples before treatment. The goal is to see if these tools can accurately detect how far the cancer has spread, potentially reducing the need for invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FAPI PET/CT scan and liquid biopsy (urine tests)
What this could lead to: If successful, this could lead to more accurate staging of bladder cancer without invasive procedures, helping doctors choose the best treatment.
What could go wrong: This is a phase 2 trial, so it is still early. The new imaging and tests may not prove more accurate than current methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.